Abel Hall LLC
GH icon

Abel Hall LLC’s Guardant Health GH Stock Holding History

Abel Hall LLC’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.41M Sell
7,902
-58
-0.7% -$9.48K 0.25% 48
2026
Q2 		$1.19M Buy
7,960
+3,409
+75% +$371K 0.21% 63
2026
Q1 		$420K Buy
4,551
+18
+0.4% +$1.81K 0.09% 255
2025
Q4 		$463K Buy
4,533
+751
+20% +$67.2K 0.11% 192
2025
Q3 		$236K Sell
3,782
-100
-3% -$5.44K 0.1% 231
2025
Q2 		$202K Buy
+3,882
New +$173K 0.09% 232

Other funds holding GH

Slow Capital
Slow Capital Greenbrae, California $890M AUM 40.96% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
SWS Partners
SWS Partners Columbus, Ohio $465M AUM 35.11% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Triasima Portfolio Management
Triasima Portfolio Management Montreal, Quebec, Canada $758M AUM 48.16% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Krilogy Financial
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Abel Hall LLC's GH Position: Q3 2026 in Review

Abel Hall LLC reduced its Guardant Health (GH) stake by 0.73% in Q3 2026, selling an estimated $9.48K and leaving 7,902 shares worth $1.41M. The position accounts for 0.25% of the portfolio, ranked #48.

Abel Hall LLC first reported a position in GH in Q2 2025 and has held it in 6 quarters since. 137 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Abel Hall LLC held 7,902 shares of Guardant Health worth $1.41M as of Q3 2026.
  • Abel Hall LLC sold 58 Guardant Health shares in Q3 2026, an estimated $9.48K.
  • Guardant Health made up 0.25% of Abel Hall LLC's portfolio in Q3 2026, its #48 holding.
  • Abel Hall LLC first reported a position in Guardant Health in Q2 2025 and has held it in 6 quarters since.
  • 137 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.